Abstract:Introduction: Effect of H.pylori eradication of H.pylori infection-associated MALT lymphoma. Methods: A 32-year-old woman was seen complaining of intermittent epigastric pain of 1 year’s duration, with loss of appetite, frequent nausea, occasional acid reflux, and vomiting. She was diagnosed with a gastric ulcer after endoscopic examination performed at another facility. Due to the non-healing, she came to our outpatient department for further management. She denied diarrhea, unusual defecation, fever, chills, and night sweats. She reported no history of chronic diseases, no smoking or drinking history, no family history of gastrointestinal cancer. EGD performed in our hospital showed that gastric angle mucosa is slightly hard, with scattered small irregular-shaped ulcers (Figure 1), and biopsy showed many small lymphocytes with circular or irregular cores, dense cytoplasm and not much cytoplasm, proliferating and infiltrating in lamina propria, and muscularis mucosa and formation of lymphoid follicles. Immature plasma cell proliferation in lamina propria, as well as active inflammation, epithelial erosion, acute inflammatory exudation, and ulceration were seen. CBC revealed WBC 5000/μL, platelets 201000/μL, and hemoglobin 151g/dL. Serology showed that liver and kidney functions are normal. H. pylori stool antigen was positive. Based on the findings, a diagnosis of H. pylori-related mucosa-associated lymphoid tissue (MALT) was made. Trunk and brain positron emission tomography-computed tomography (PET-CT) illustrated no significant increase of glucose metabolism in the stomach wall and no lymphoma-involved sign in the whole imaging area. According to Lugano staging of gastrointestinal lymphoma, this case was classified as IE1-stage. We treated this patient with quadruple H. pylori eradication therapy for 4 weeks, and she reported disappearance of the above symptoms and weight gain or 2 kilogram at the time of follow-up after 4-weeks treatment. Results: Ten weeks later, she was completely asymptomatic and her repeat EGD was negative for any mucosal lesion (Figure 2). Pathology examination of biopsy specimens from the gastric mucosa was normal. Conclusion: It is important to insure complete healing of gastric ulcers since, as in our case, there may be an underlying malignant reason for non-healing. Our patient had an early-stage MALT, which achieves complete remission after H. pylori eradication, but she will still require periodic follow-up to exclude late recurrence, especially if there is reinfection with H. pylori.

Helicobacter pylori Eradication Therapy for Colorectal Mucosa-associated Lymphoid Tissue Lymphoma: Report of Two Cases

Diagnosis and Treatment of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma

Case Report: H. Pylori Infection-Associated Malt Lymphoma

Transformed gastric mucosa-associated lymphoid tissue lymphoma originating in the colon and developing metachronously after Helicobacter pylori eradication: A case report

Role of Helicobacter Pylori Virulence Factor Cytotoxin-Associated Gene A in Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Helicobacter pylori eradication treatment for primary gastric diffuse large B-cell lymphoma: A single-center analysis

Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management

Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma

Effect of Helicobacter Pylori Eradication on Hyperplastic Gastric Polyps: A Systematic Review and Meta‐analysis

18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Findings in Mucosa-Associated Lymphoid Tissue Lymphoma of the Larynx: A Case Report and Literature Review

The Clinical Value of Apoptosis Protein 2-Mucosa Associated Lymphoid Tissue Lymphoma Translocation Gene 1 Fusion Gene Detection in Tissue of Primary Gastric Lymphoma

[Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report]

Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up

Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy

Serial regression of primary gastric diffuse large B cell lymphoma after Helicobacter pylori eradication therapy: A case report

Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

BCL10 Nuclear Expression and T(11;18)(q21;q21) Indicate Nonresponsiveness to Helicobacter Pylori Eradication of Chinese Primary Gastric MALT Lymphoma

Association of BCL10 Nuclear Expression and Non-response of Gastric Mucosa-associated Lymphoid Tissue Lymphoma to Helicobacter pylori Eradication

Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for Helicobacter pylori?

Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management

Helicobacter pylori-Associated Extranodal Marginal Zone Lymphoma of Mucosa-Associated Tissue in Children: A Multicenter Case Series